⌘K

Login Start Free

Home/Filings/4/0001209191-23-037092

4//SEC Filing

GANNON STEVEN 4

Accession 0001209191-23-037092

CIK 0001805890other

View on SEC.gov Company Profile

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 5:07 PM ET

Size

5.4 KB

Accession

0001209191-23-037092

Insider Transaction Report

Form 4

Period: 2023-06-14

Fusion Pharmaceuticals Inc.FUSN

Director

Transactions

Award
Stock Option (Right to Buy)
2023-06-14+17,000→ 17,000 total
Exercise: $4.64Exp: 2033-06-13→ Common Stock (17,000 underlying)

Footnotes (1)

[F1]This option fully vests on the earlier of (i) June 14, 2024 or (ii) the 2024 Annual Meeting of Shareholders of Fusion Pharmaceuticals Inc.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Fusion Pharmaceuticals Inc.

CIK 0001805890

Entity typeother

Related Parties

1

filerCIK 0001643085

Filing Metadata

Form type: 4
Filed: Jun 13, 8:00 PM ET
Accepted: Jun 14, 5:07 PM ET
Size: 5.4 KB

View on SEC.gov